Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 63Breast Neoplasms 28Neoplasms 5Neoplasm Metastasis 3Leiomyoma 3Cardiovascular Diseases 3Polycystic Ovary Syndrome 2Neoplasms by Site 2Endometrial Neoplasms 2Breast Diseases 2Advanced Breast Cancer 2Stage II Prostate Adenocarcinoma 1Sleep Wake Disorders 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sarcopenia 1Salivary Gland Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Pelvic Pain 1Ovarian Neoplasms 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Metastatic Neuroendocrine Prostate Cancer 1

Interventions

Fulvestrant 19Letrozole 10Anastrozole 8Capecitabine 5palbociclib 4olaparib 4Paclitaxel 4Injections 4Goserelin 4Docetaxel 4trastuzumab deruxtecan 3pyrotinib 3exemestane 3Vinorelbine 3Aromatase Inhibitors 3toripalimab 2sacituzumab govitecan 2ribociclib 2eribulin 2elacestrant 2dalpiciclib 2abemaciclib 2Trastuzumab 2Gonadotropin-Releasing Hormone 2FCN-437c 2Everolimus 2Dasatinib 2Alpelisib 2Albumin-Bound Paclitaxel 2AZD9833 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Gonadotropin-Releasing Hormone × Clear all
NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

NCT01311037 2011-12-13

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center

Unknown
2 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡